Tirzepatide40
2100 Inquiries
2023788-19-2
Pharmaceutical Grade
99.9%
GUANGZHOU
Available in multiple specifications, 10 pieces per box.
2026-07-11
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,GHK-Cu
-
Location:
RM 701, UNIT 108, 7/F, TWR B NEW MANDARIN PLAZA 14 SCIENCE MUSEUM RD TSIM SHA TSUI HONG KONG
-
Year of Establishment:
2026
-
-
Inquiry History2100 Inquiries
Country Product Purchase Quantity Date Posted
United States
Tirzepatide
60 MG Oct 28, 2026
United States
Tirzepatide
10 PCS Oct 28, 2026
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026
United States
Tirzepatide
50 MG Oct 20, 2026
Spain
tirzepatide
20 MG Oct 19, 2026
United States
tirzepatide
30 MG Oct 19, 2026 Post an enquiry for this product
More from this Seller
-
-
-
A-I-C-A-R / 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
Research Grade / 99%
$55-57/BOU FOB
-
-
-
-
High Purity SLU-PP-322 (SLU-PP-332) Synthetic ERR Agonist Research Chemical Powder CAS 303760-60-3 for Laboratory Research Only
Pharmaceutical Grade / 99%
$84-85/BOU FOB
-
-
-
-
Eloralintide Research Grade Synthetic Peptide Lyophilized White Powder, HPLC 99%, For In Vitro Non-Clinical Laboratory Research Only
Research Grade / 99%
$51-55/BOU FOB
-
-
-
-
Semorelin Acetate Lyophilized Acetate Salt Short Linear Peptide White Crystal Powder
Pharmaceutical Grade / 99.9%
$10-11/BOU FOB
-
-
-
-
LR3 Insuli-Like Growth Factor-1 High Purity Recombinant Peptide Lyophilized Raw Material for Research
Pharmaceutical Grade / 99%
$40-45/BOU FOB
-
-
-
-
Benzyl Alcohol 0.9% BAC Aqueous Solution, Laboratory Grade Preservative Solvent
Pharmaceutical Grade / 99%
$6-7/BOU FOB
-